Correlation Between Tonix Pharmaceuticals and Sonnet Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Sonnet Biotherapeutics.

Diversification Opportunities for Tonix Pharmaceuticals and Sonnet Biotherapeutics

0.03

Correlation Coefficient

Tonix Pharmaceuticals  Sonnet Biotherapeutics

Significant diversification

The 3 months correlation between Tonix and Sonnet is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between Tonix Pharmaceuticals and Sonnet Biotherapeutics

Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to generate 1.14 times more return on investment than Sonnet Biotherapeutics. However, Tonix Pharmaceuticals is 1.14 times more volatile than Sonnet Biotherapeutics Holdings. It trades about 0.0 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.14 per unit of risk. If you would invest  23.00  in Tonix Pharmaceuticals Holding on August 30, 2024 and sell it today you would lose (4.00) from holding Tonix Pharmaceuticals Holding or give up 17.39% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tonix Pharmaceuticals Holding  vs.  Sonnet Biotherapeutics Holding

Tonix Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tonix Pharmaceuticals Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Tonix Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Sonnet Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Tonix Pharmaceuticals and Sonnet Biotherapeutics

The main advantage of trading using opposite Tonix Pharmaceuticals and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.

The idea behind Tonix Pharmaceuticals Holding and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.